Controlled trial of cimetidine for symptomatic treatment of duodenal ulcers

Michael P Lance, B. G. Gazzard

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Over 10% of the population may expect to have a duodenal ulcer during their lifetime; most are treated with cimetidine. Most trials so far have concentrated on completely healing ulcers using short term courses of this drug. Prob Probably, many patients take the drug only until their symptoms resolve, after one to two weeks. We therefore conducted a prospective trial of cimetidine taken for six weeks versus cimetidine taken only until symptoms were relieved in patients with active duodenal ulceration.

Original languageEnglish (US)
Pages (from-to)937-938
Number of pages2
JournalBMJ (Clinical research ed.)
Volume286
Issue number6369
StatePublished - 1983
Externally publishedYes

Fingerprint

Cimetidine
Duodenal Ulcer
Pharmaceutical Preparations
Curriculum
Ulcer
Therapeutics
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Controlled trial of cimetidine for symptomatic treatment of duodenal ulcers. / Lance, Michael P; Gazzard, B. G.

In: BMJ (Clinical research ed.), Vol. 286, No. 6369, 1983, p. 937-938.

Research output: Contribution to journalArticle

@article{fcd44c41948c45129ba0a698ca4c9c14,
title = "Controlled trial of cimetidine for symptomatic treatment of duodenal ulcers",
abstract = "Over 10{\%} of the population may expect to have a duodenal ulcer during their lifetime; most are treated with cimetidine. Most trials so far have concentrated on completely healing ulcers using short term courses of this drug. Prob Probably, many patients take the drug only until their symptoms resolve, after one to two weeks. We therefore conducted a prospective trial of cimetidine taken for six weeks versus cimetidine taken only until symptoms were relieved in patients with active duodenal ulceration.",
author = "Lance, {Michael P} and Gazzard, {B. G.}",
year = "1983",
language = "English (US)",
volume = "286",
pages = "937--938",
journal = "The BMJ",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
number = "6369",

}

TY - JOUR

T1 - Controlled trial of cimetidine for symptomatic treatment of duodenal ulcers

AU - Lance, Michael P

AU - Gazzard, B. G.

PY - 1983

Y1 - 1983

N2 - Over 10% of the population may expect to have a duodenal ulcer during their lifetime; most are treated with cimetidine. Most trials so far have concentrated on completely healing ulcers using short term courses of this drug. Prob Probably, many patients take the drug only until their symptoms resolve, after one to two weeks. We therefore conducted a prospective trial of cimetidine taken for six weeks versus cimetidine taken only until symptoms were relieved in patients with active duodenal ulceration.

AB - Over 10% of the population may expect to have a duodenal ulcer during their lifetime; most are treated with cimetidine. Most trials so far have concentrated on completely healing ulcers using short term courses of this drug. Prob Probably, many patients take the drug only until their symptoms resolve, after one to two weeks. We therefore conducted a prospective trial of cimetidine taken for six weeks versus cimetidine taken only until symptoms were relieved in patients with active duodenal ulceration.

UR - http://www.scopus.com/inward/record.url?scp=0020682037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020682037&partnerID=8YFLogxK

M3 - Article

VL - 286

SP - 937

EP - 938

JO - The BMJ

JF - The BMJ

SN - 0959-8146

IS - 6369

ER -